302 related articles for article (PubMed ID: 21502705)
1. Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.
Xu H; Yang YJ; Qian HY; Tang YD; Wang H; Zhang Q
Circ J; 2011; 75(6):1476-85. PubMed ID: 21502705
[TBL] [Abstract][Full Text] [Related]
2. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction.
Negoro S; Kunisada K; Tone E; Funamoto M; Oh H; Kishimoto T; Yamauchi-Takihara K
Cardiovasc Res; 2000 Sep; 47(4):797-805. PubMed ID: 10974228
[TBL] [Abstract][Full Text] [Related]
3. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
[TBL] [Abstract][Full Text] [Related]
4. Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction.
Khan I; Ali A; Akhter MA; Naeem N; Chotani MA; Iqbal H; Kabir N; Atiq M; Salim A
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039940
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts.
Yang YJ; Qian HY; Huang J; Li JJ; Gao RL; Dou KF; Yang GS; Willerson JT; Geng YJ
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2076-82. PubMed ID: 19762786
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
Chen JJ; Zhou SH
Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling.
Eid RA; Alkhateeb MA; Eleawa S; Al-Hashem FH; Al-Shraim M; El-Kott AF; Zaki MSA; Dallak MA; Aldera H
Basic Res Cardiol; 2018 Feb; 113(2):13. PubMed ID: 29392420
[TBL] [Abstract][Full Text] [Related]
10. Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heart.
Huffman LC; Koch SE; Butler KL
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H257-62. PubMed ID: 17982005
[TBL] [Abstract][Full Text] [Related]
11. Influence of mesenchymal stem cells on respiratory distress syndrome in newborn swines via the JAK-STAT signaling pathway.
Wang HZ; Yang C; Zhang BY; Li N; Han Z; Chen F
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7550-7556. PubMed ID: 31539145
[TBL] [Abstract][Full Text] [Related]
12. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
[TBL] [Abstract][Full Text] [Related]
13. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Hermida N; Markl A; Hamelet J; Van Assche T; Vanderper A; Herijgers P; van Bilsen M; Hilfiker-Kleiner D; Noppe G; Beauloye C; Horman S; Balligand JL
Cardiovasc Res; 2013 Jul; 99(1):44-54. PubMed ID: 23542580
[TBL] [Abstract][Full Text] [Related]
14. The functional role of the JAK-STAT pathway in post-infarction remodeling.
El-Adawi H; Deng L; Tramontano A; Smith S; Mascareno E; Ganguly K; Castillo R; El-Sherif N
Cardiovasc Res; 2003 Jan; 57(1):129-38. PubMed ID: 12504822
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin treatment improves the effects of mesenchymal stem cell transplantation on acute myocardial infarction: the role of the RhoA/ROCK/ERK pathway.
Zhang Q; Wang H; Yang YJ; Dong QT; Wang TJ; Qian HY; Li N; Wang XM; Jin C
Int J Cardiol; 2014 Oct; 176(3):670-9. PubMed ID: 25139321
[TBL] [Abstract][Full Text] [Related]
16. JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients.
Ji J; Wu Y; Meng Y; Zhang L; Feng G; Xia Y; Xue W; Zhao S; Gu Z; Shao X
Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):208-215. PubMed ID: 28177455
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.
Song L; Yang YJ; Dong QT; Qian HY; Gao RL; Qiao SB; Shen R; He ZX; Lu MJ; Zhao SH; Geng YJ; Gersh BJ
PLoS One; 2013; 8(5):e65702. PubMed ID: 23741509
[TBL] [Abstract][Full Text] [Related]
18. Regulating RISK: a role for JAK-STAT signaling in postconditioning?
Goodman MD; Koch SE; Fuller-Bicer GA; Butler KL
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1649-56. PubMed ID: 18708442
[TBL] [Abstract][Full Text] [Related]
19. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
[TBL] [Abstract][Full Text] [Related]
20. Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway.
Xin LH; Liu R; Yang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):409-417. PubMed ID: 31957855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
